Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer
NCT ID: NCT02101528
Last Updated: 2014-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2013-01-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease
NCT07172698
Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training
NCT01971528
Exploring Sarcopenia in Parkinson's Disease Patients by Combining Serum Biomarker Levels
NCT06511531
Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease
NCT07095400
Analysis of the Parameters Obtained on Stabilometric Platform in Patients With PD
NCT02098655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Decreased muscle strength has been reported to be a factor contributing to increased incidences of falling in the elderly patients causing fractures, joint dislocations, severe soft tissue lesions and head trauma. Parkinson's Disease (PD) patients often complain of weakness and it has been reported that they have reduced muscle strength, decreased rate of force development, impaired ability to maintain constant force, and increased muscle coactivation during balance perturbation tasks. The specific cause of this weakness is not known, and in this study the investigators have analyzed and measured isokinetic muscle strength in PD patients to clarify this issue. the investigators have compared the data obtained with those of age-matched controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD Patients
PD patients with a diagnosis of "clinically probable" idiopathic PD in Hoehn-Yahr stage 2-3, with the ability to walk without any assistance, with mini-mental state examination score ≥26, without any relevant comorbidity or vestibular/visual dysfunctions limiting locomotion or balance.
No interventions assigned to this group
Controls
age and sex matched healthy volunteers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* PD patients with relevant orthopedic
* Rheumatic and muscular conditions
55 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Generale Di Zona Moriggia-Pelascini
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Frazzitta, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale Generale di Zona "Moriggia-Pelascini", Gravedona ed Uniti (CO), Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Salvatore Maugeri
Montescano, Pavia, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CybexPD001
Identifier Type: OTHER
Identifier Source: secondary_id
CybexPD001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.